Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v3-FR
Language English French
Date Updated 2018-12-18 2018-10-10
Drug Identification Number 02341611 02341611
Brand name REVATIO REVATIO
Common or Proper name REVATIO REVATIO
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients SILDENAFIL SILDENAFIL
Strength(s) 0.8MG 0.8MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1x 12.5ML VIAL 1x 12.5ML VIAL
ATC code C02KX C02KX
ATC description OTHER ANTIHYPERTENSIVES OTHER ANTIHYPERTENSIVES
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2018-10-09 2018-10-09
Estimated end date 2018-12-12
Actual end date 2018-12-17
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments